Supporting Global Innovation from Australia and the United States.

LORAI Health maintains research and business operations in both Australia and the US, supporting the company's global development strategy.

Our operational footprint reflects the international nature of healthcare innovation and enables collaboration across research, technology, manufacturing and commercialisation.

Through activities in both countries, LORAI Health is building the foundations required to support the development of next generation transdermal technologies for global markets.

LORAI Health LLC supports the company's research and business activities within the United States.

Our US operations provide access to scientific expertise, innovation infrastructure and strategic partnerships that support the advancement of both our technology platforms and our long-term growth objectives.

Delaware Innovation Space

We conduct activities through the Delaware Innovation Space, a leading innovation ecosystem supporting science and technology companies.

This environment provides us with access to research infrastructure, industry networks and collaborative opportunities that support the development of our advanced healthcare technologies.

LORAI Health LLC's US based research and development activities are focused on developing the company's Gen-2 transdermal platform.

These activities contribute to the ongoing evaluation of next generation approaches to transdermal drug delivery, with a focus on improving patient experience, treatment continuity and future manufacturing capability.

Our research programs are conducted in collaboration with scientific advisors, technical specialists and industry partners as appropriate.

USA Operations

US Leadership

  • Dr Raisa Monteiro

    CHIEF EXECUTIVE OFFICER

  • Dr Alex Ionkin

    CHIEF TECHNOLOGY OFFICER

Building a Global Company

LORAI Health was founded in Australia and continues to expand its international operational footprint as the company progresses its technology development and commercialisation strategy.

Our presence in the US reflects a long-term commitment to building the scientific, operational and leadership capabilities required to support global growth.

By combining Australian origins with international expertise and partnerships, LORAI Health is positioning itself to contribute to the future of transdermal drug delivery innovation.